APA (7th ed.) Citation

R, Z., L, C., X, L., J, Z., K, H., T, H., . . . HG, W. (2026). Targeting VPS4 elicits STING-driven anti-tumor immunity to suppress rhabdomyosarcoma growth. Oncogene, 45(23), 2211. https://doi.org/10.1038/s41388-026-03800-1

Chicago Style (17th ed.) Citation

R, Zhang, et al. "Targeting VPS4 Elicits STING-driven Anti-tumor Immunity to Suppress Rhabdomyosarcoma Growth." Oncogene 45, no. 23 (2026): 2211. https://doi.org/10.1038/s41388-026-03800-1.

MLA (9th ed.) Citation

R, Zhang, et al. "Targeting VPS4 Elicits STING-driven Anti-tumor Immunity to Suppress Rhabdomyosarcoma Growth." Oncogene, vol. 45, no. 23, 2026, p. 2211, https://doi.org/10.1038/s41388-026-03800-1.